Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study

BACKGROUND: One of the main pathophysiological mechanisms underlying the severe course of COVID-19 is the hyper-inflammatory syndrome associated with progressive damage of lung tissue and multi-organ dysfunction. IL-17 has been suggested to be involved in hyper-inflammatory syndrome. OBJECTIVE: To e...

Descripción completa

Detalles Bibliográficos
Autores principales: Avdeev, Sergey N., Trushenko, Natalia V., Tsareva, Natalia A., Yaroshetskiy, Andrey I., Merzhoeva, Zamira M., Nuralieva, Galia S., Nekludova, Galina V., Chikina, Svetlana Yu., Gneusheva, Tatiana Yu., Suvorova, Olga A., Shmidt, Anna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253694/
https://www.ncbi.nlm.nih.gov/pubmed/34237556
http://dx.doi.org/10.1016/j.cyto.2021.155627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253694/
https://www.ncbi.nlm.nih.gov/pubmed/34237556
http://dx.doi.org/10.1016/j.cyto.2021.155627

Ejemplares similares